generalized myasthenia gravis

BOSTON, Massachusetts — September 8, 2026 Vor Bio announced the completion of enrollment in UPSTREAM MG, its global Phase...

GENEVA, Switzerland, June 26, 2026 Johnson & Johnson presented 12 new scientific abstracts at the European Academy of Neurology...

AMSTERDAM, Netherlands, May 8, 2026 Argenx SE announced that the U.S. Food and Drug Administration (FDA) has approved a...

Horsham, Pennsylvania, USA – April 22, 2026 In a major advancement for autoimmune neurology, Johnson & Johnson has reported...

Tarrytown, New York, USA – April 21, 2026 In a significant breakthrough for autoimmune neurology, Regeneron Pharmaceuticals has reported...

MAHWAH, N.J., January 29, 2026 — KORU Medical Systems has received U.S. FDA 510(k) clearance expanding the labeled use...